These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29083051)

  • 21. Role of methicillin-resistant Staphylococcus aureus in head and neck infections.
    Brook I
    J Laryngol Otol; 2009 Dec; 123(12):1301-7. PubMed ID: 19664316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case of coincident severe acne and psoriasis in AIDS patient successfully treated with antiretroviral therapy.
    Li YY; Dong RJ; Cao LJ; Upadhyay P; Kuang YQ
    J Dermatol; 2019 May; 46(5):431-435. PubMed ID: 30811070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.
    Papp KA; Leonardi C; Menter A; Ortonne JP; Krueger JG; Kricorian G; Aras G; Li J; Russell CB; Thompson EH; Baumgartner S
    N Engl J Med; 2012 Mar; 366(13):1181-9. PubMed ID: 22455412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and epidemiologic characteristics as predictors of treatment failures in uncomplicated skin abscesses within seven days after incision and drainage.
    Olderog CK; Schmitz GR; Bruner DR; Pittoti R; Williams J; Ouyang K
    J Emerg Med; 2012 Oct; 43(4):605-11. PubMed ID: 22698825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric Staphylococcus aureus Infections: Impact of Methicillin Resistance at a Canadian Center.
    Fanella S; Embree J
    South Med J; 2015 May; 108(5):254-7. PubMed ID: 25972209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of brodalumab for the treatment of psoriasis.
    Iznardo H; Puig L
    Expert Opin Drug Saf; 2020 Apr; 19(4):365-372. PubMed ID: 32053396
    [No Abstract]   [Full Text] [Related]  

  • 27. Brodalumab: A Review in Moderate to Severe Plaque Psoriasis.
    Blair HA
    Drugs; 2018 Mar; 78(4):495-504. PubMed ID: 29516365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis.
    Galluzzo M; Talamonti M; D'adamio S; Bianchi L
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):679-691. PubMed ID: 28460549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmitted Pulsations from a Mediastinal Abscess.
    Xu B; Mandsager KT
    Am J Med; 2017 Sep; 130(9):e397-e398. PubMed ID: 28390790
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe myalgia associated with brodalumab treatment in a patient with psoriasis.
    Ichiyama S; Matano Y; Hoashi T; Kanda N; Nagayama H; Saeki H
    J Dermatol; 2018 Dec; 45(12):e327-e328. PubMed ID: 29782052
    [No Abstract]   [Full Text] [Related]  

  • 31. Skin and soft tissue infections.
    Zubair MH; Alvi S; Zubair MH
    J Pak Med Assoc; 2010 Jun; 60(6):513-4. PubMed ID: 20527663
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bacterial lip abscess in an immunocompetent patient].
    Godoy-Gijón E; del Pozo-de Dios JC; Román-Curto C
    Dermatol Online J; 2013 Apr; 19(4):13. PubMed ID: 24021372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
    Lebwohl M; Strober B; Menter A; Gordon K; Weglowska J; Puig L; Papp K; Spelman L; Toth D; Kerdel F; Armstrong AW; Stingl G; Kimball AB; Bachelez H; Wu JJ; Crowley J; Langley RG; Blicharski T; Paul C; Lacour JP; Tyring S; Kircik L; Chimenti S; Callis Duffin K; Bagel J; Koo J; Aras G; Li J; Song W; Milmont CE; Shi Y; Erondu N; Klekotka P; Kotzin B; Nirula A
    N Engl J Med; 2015 Oct; 373(14):1318-28. PubMed ID: 26422722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of biologics in psoriasis.
    Kamata M; Tada Y
    J Dermatol; 2018 Mar; 45(3):279-286. PubMed ID: 29226369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rebound pustular psoriasis after brodalumab discontinuation.
    Khemis A; Cavalié M; Montaudié H; Lacour JP; Passeron T
    Br J Dermatol; 2016 Nov; 175(5):1065-1066. PubMed ID: 27037661
    [No Abstract]   [Full Text] [Related]  

  • 36. A Case of Autoimmune Hepatitis during Brodalumab Treatment for Psoriasis.
    Serizawa N; Hoashi T; Saeki H; Kanda N
    J Nippon Med Sch; 2020; 87(6):359-361. PubMed ID: 33431762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal septal abscess and facial cellulitis caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Cheng LH; Kang BH
    J Laryngol Otol; 2010 Sep; 124(9):1014-6. PubMed ID: 20056011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials.
    McMichael A; Desai SR; Qureshi A; Rastogi S; Alexis AF
    Am J Clin Dermatol; 2019 Apr; 20(2):267-276. PubMed ID: 30471012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brodalumab: A Review of Safety.
    Rusta-Sallehy S; Gooderham M; Papp K
    Skin Therapy Lett; 2018 Mar; 23(2):1-3. PubMed ID: 29562088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recapture Rate of Brodalumab in Patients With a Lapse in Treatment.
    Lebwohl M; Cather J; Armstrong A; Van Voorhees A; Jacobson A
    J Drugs Dermatol; 2020 Apr; 19(4):384-387. PubMed ID: 32272515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.